<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887457/bin/bcr-2019-231464f02.jpg"/> </div> <div class="text-side"> <h1>Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment.</h1> <p>Pyogenic granuloma. Under the epidermis, capillary vessels showing leafy densification were observed. Vascular endothelial cells showed mild nuclear enlargement. Oedema, bleeding and mild inflammatory cell infiltration were seen in the interstitium. Malignant cells were not observed and findings were consistent with pyogenic granuloma ((A) H&amp;E staining; ×100 (left), ×400 (right)). Strong staining of VEGFR2 was observed in almost all vascular endothelial cells ((B) VEGFR2 immunostaining; ×400). TK1, a cell proliferation marker, was also frequently detected ((C) TK1/CD31 double immunostaining; ×400). VEGFR2, vascular endothelial growth factor receptor-2.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31776151/" target="_blank">31776151</a></p><p>Type: Benign, Category: Vascular</p>
</div> </div></div></body></html>